| Edição |
Título |
Arquivo |
| Volume 31, Nº 14 (2024) |
MicroRNA-mediated Regulation of LDL Receptor: Biological and Pharmacological Implications |
(Eng)
|
|
Keshavarz R., Reiner ., Zengin G., Eid A., Sahebkar A.
|
| Volume 31, Nº 22 (2024) |
miR-204-5p Plays a Critical Role in the Pathogenesis of Depression and Anti-depression Action of Venlafaxine in the Hippocampus of Mice |
(Eng)
|
|
Guan W., Wu X., Jin X., Sheng X., Fan Y.
|
| Volume 31, Nº 18 (2024) |
miR-26a is a Key Therapeutic Target with Enormous Potential in the Diagnosis and Prognosis of Human Disease |
(Eng)
|
|
Guan W., Chen Y., Fan Y.
|
| Volume 31, Nº 6 (2024) |
Mitapivat: A Novel Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency |
(Eng)
|
|
De S.
|
| Volume 31, Nº 19 (2024) |
Modulation of the HIF-1α-NCOA4-FTH1 Signaling Axis Regulating Ferroptosis-induced Hepatic Stellate Cell Senescence to Explore the Anti-hepatic Fibrosis Mechanism of Curcumol |
(Eng)
|
|
Zheng Y., Wang L., Wang J., Zhao T., Wang J.
|
| Volume 31, Nº 32 (2024) |
Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy |
(Eng)
|
|
Vijayan Y., Sandhu J., Harikumar K.
|
| Volume 31, Nº 20 (2024) |
Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation |
(Eng)
|
|
Zhong H., Liu H., Liu H.
|
| Volume 31, Nº 36 (2024) |
Molecular Mechanisms and Therapeutic Potential of Resolvins in Cancer - Current Status and Perspectives |
(Eng)
|
|
Tajbakhsh A., Yousefi F., Farahani N., Savardashtaki A., Reiner ., Jamialahmadi T., Sahebkar A.
|
| Volume 31, Nº 34 (2024) |
Molecular Subtypes and Prognostic Models for Predicting Prognosis of Lung Adenocarcinoma based on MiRNA-related Genes |
(Eng)
|
|
Wei Y., Zhong W., Bi Y., Liu X., Zhou Q., Liu J., Wang M., Zhang H., Chen M.
|
| Volume 31, Nº 19 (2024) |
Multimodality Cardiac Imaging Biomarkers and Atrial Fibrillation Substrate: Are they Worthwhile? |
(Eng)
|
|
Androulakis E., Ahsan S., Papageorgiou N.
|
| Volume 31, Nº 25 (2024) |
Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma |
(Eng)
|
|
Liu J., Li H., Zhang N., Dong Q., Liang Z.
|
| Volume 31, Nº 40 (2024) |
Multi-omics Combined with Machine Learning Facilitating the Diagnosis of Gastric Cancer |
(Eng)
|
|
Li J., Xu S., Zhu F., Shen F., Zhang T., Wan X., Gong S., Liang G., Zhou Y.
|
| Volume 31, Nº 38 (2024) |
Multi-omics Data Integration Analysis Identified Therapeutic Targets and Potential Reuse Drugs for Osteoporosis |
(Eng)
|
|
Li M., Gao X., Zhang Y., Wang J., Dong R., Li P., He Y.
|
| Volume 31, Nº 13 (2024) |
Multiple Natural Polymers in Drug and Gene Delivery Systems |
(Eng)
|
|
Jiang Z., Song Z., Cao C., Yan M., Liu Z., Cheng X., Wang H., Wang Q., Liu H., Chen S.
|
| Volume 31, Nº 22 (2024) |
Multiple Protein Biomarkers and Different Treatment Strategies for Colorectal Carcinoma: A Comprehensive Prospective |
(Eng)
|
|
Chakraborty B., Agarwal S., Kori S., Das R., Kashaw V., Iyer A., Kashaw S.
|
| Volume 31, Nº 29 (2024) |
Mycobacterial Targets for Thiourea Derivatives: Opportunities for Virtual Screening in Tuberculosis Drug Discovery |
(Eng)
|
|
de Melo Milani V., Silva M., Camargo P., de Lima Ferreira Bispo M.
|
| Volume 31, Nº 28 (2024) |
Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy |
(Eng)
|
|
Gautam R., Mittal P., Goyal R., Dua K., Mishra D., Sharma S., Singla R.
|
| Volume 31, Nº 7 (2024) |
Natural Anticancer Agents: Their Therapeutic Potential, Challenges and Promising Outcomes |
(Eng)
|
|
Tauro S., Dhokchawle B., Mohite P., Nahar D., Nadar S., Coutinho E.
|
| Volume 31, Nº 7 (2024) |
Natural Coumarin Derivatives Targeting Melanoma |
(Eng)
|
|
Silva L., Nunes J., Zhan P., Łączkowski K., Cardoso S., da Silva-Júnior E.
|
| Volume 31, Nº 26 (2024) |
Natural Phenolic Compounds with Antithrombotic and Antiplatelet Effects: A Drug-likeness Approach |
(Eng)
|
|
Fernandes D., Gomes A., da Silva C., de Medeiros Henriques I., de Menezes R., Scotti M., Teles Y., Edrada-Ebel R., de Fatima Vanderlei de Souza M.
|
| Volume 31, Nº 31 (2024) |
Natural Plant Materials as a Source of Neuroprotective Peptides |
(Eng)
|
|
Skibska A., Perlikowska R.
|
| Volume 31, Nº 31 (2024) |
Natural Products in Liver Fibrosis Management: A Five-year Review |
(Eng)
|
|
Wang T., Lu Z., Sun G., He K., Chen Z., Qu X., Han X.
|
| Volume 31, Nº 1 (2024) |
Naturally Occurring Xanthones; Biological Activities, Chemical Profiles and In Silico Drug Discovery |
(Eng)
|
|
El-Seedi H., Ibrahim H., Yosri N., Ibrahim M., Hegazy M., Setzer W., Guo Z., Zou X., Refaey M., Salem S., Musharraf S., Saeed A., Salem S., Xu B., Zhao C., Khalifa S.
|
| Volume 31, Nº 32 (2024) |
Natures Elixir for Cancer Treatment: Targeting Tumor-induced Neovascularization |
(Eng)
|
|
Kumari R., Syeda S., Shrivastava A.
|
| Volume 31, Nº 38 (2024) |
Neuroprotective Effect of Natural Indole and β-carboline Alkaloids against Parkinsons Disease: An Overview |
(Eng)
|
|
Shome A., Chahat ., Chawla V., Chawla P.
|
| Volume 31, Nº 23 (2024) |
Neuroprotective Properties of Antiepileptics: What are the Implications for Psychiatric Disorders? |
(Eng)
|
|
Dell'Osso L., Nardi B., Massoni L., Gravina D., Benedetti F., Cremone I., Carpita B.
|
| Volume 31, Nº 20 (2024) |
Neurosteroids and their Therapeutic Potential: Remembering the Contribution of Dr. Sabina Luchetti, Netherlands Institute for Neuroscience, Amsterdam, Netherlands |
(Eng)
|
|
di Michele F.
|
| Volume 31, Nº 11 (2024) |
New Insights into the Long Non-coding RNAs Dependent Modulation of Heart Failure and Cardiac Hypertrophy: From Molecular Function to Diagnosis and Treatment |
(Eng)
|
|
Rezaee M., Masihipour N., Milasi Y., Dehmordi R., Reiner ., Asadi S., Mohammadi F., Khalilzadeh P., Rostami M., Asemi Z., Mafi A.
|
| Volume 31, Nº 21 (2024) |
New Molecules of Importance in the Prevention and Treatment of Acne: A Systematic Patent Review (2016-2020) |
(Eng)
|
|
Calderón-Pardo D., Serafini M., Alves I., Aragón D.
|
| Volume 31, Nº 33 (2024) |
New Pyrrolopyrimidines as LRRK2 Inhibitors for Treating Parkinson's Disease |
(Eng)
|
|
De S.
|
| Volume 31, Nº 9 (2024) |
NLS-3 (Levophacetoperane or (R,R) Phacetoperane): A Reverse Ester of Methylphenidate: A Literature Review |
(Eng)
|
|
Konofal E., Lecendreux M., Bizot J., Lormier A., Figadère B.
|
| Volume 31, Nº 29 (2024) |
N-Methyl-D-Aspartate (NMDA) Receptor Antagonists and their Pharmacological Implication: A Medicinal Chemistry-oriented Perspective Outline |
(Eng)
|
|
Rana V., Ghosh S., Bhatt A., Bisht D., Joshi G., Purohit P.
|
| Volume 31, Nº 34 (2024) |
Non-oxidative Modified Low-density Lipoproteins: The Underappreciated Risk Factors for Atherosclerosis |
(Eng)
|
|
Zhao Y., Xu Q., He N., Jiang M., Chen Y., Ren Z., Tang Z., Wu C., Liu L.
|
| Volume 31, Nº 17 (2024) |
Non-oxidative vs Oxidative Forms of Modified Low-density Lipoprotein: What is More Important in Atherogenesis? |
(Eng)
|
|
Orekhov A., Khotina V., Sukhorukov V., Sobenin I.
|
| Volume 31, Nº 28 (2024) |
Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase |
(Eng)
|
|
Bui K., Nguyen T., Barat S., Scholta T., Xing J., Bhuria V., Sipos B., Wilkens L., Nguyen L., Le H., Velavan T., Bozko P., Plentz R.
|
| Volume 31, Nº 5 (2024) |
Novel and Latest Computational Routes in the Design and Development of Anticancer Drugs |
(Eng)
|
|
Kamal M., Akhtar S.
|
| Volume 31, Nº 40 (2024) |
Novel Anti-tumor Bio-drugs and Therapeutic Strategies in Cancer Management: From Bench to Translational Research |
(Eng)
|
|
Huang S.
|
| Volume 31, Nº 5 (2024) |
Novel Computational Methods for Cancer Drug Design |
(Eng)
|
|
Talluri S., Kamal M., Malla R.
|
| Volume 31, Nº 40 (2024) |
Novel Natural Inhibitors for Glioblastoma by Targeting Epidermal Growth Factor Receptor and Phosphoinositide 3-kinase |
(Eng)
|
|
Ullah A., Ullah S., Waqas M., Khan M., Rehman N., Khalid A., Jan A., Aziz S., Naeem M., Halim S., Khan A., Al-Harrasi A.
|
| Volume 31, Nº 4 (2024) |
Novel Perspectives for the Diagnosis and Treatment of Gynecological Cancers using Dysregulation of PIWI Protein and PiRNAs as Biomarkers |
(Eng)
|
|
Yousefi B., Sadoughi F., Asemi Z., Mansournia M., Hallajzadeh J.
|
| Volume 31, Nº 34 (2024) |
Novel Pyrazino[2,3-b] Pyrazines as mTOR Kinase Inhibitors for Treating Cancer and other Diseases |
(Eng)
|
|
De S.
|
| Volume 31, Nº 8 (2024) |
Novel Pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as Protein Kinase C Inhibitors for Treating Diseases |
(Eng)
|
|
De S.
|
| Volume 31, Nº 3 (2024) |
Novel Synthesized Tyrosinase Inhibitors: A Systematic Patent Review (2012-Present) |
(Eng)
|
|
Beltran E., Serafini M., Alves I., Aragón Novoa D.
|
| Volume 31, Nº 35 (2024) |
Nucleoside Scaffolds and Carborane Clusters for Boron Neutron Capture Therapy: Developments and Future Perspective |
(Eng)
|
|
Khalil A., Adam M.
|
| Volume 31, Nº 10 (2024) |
Oxocarbon Acids and their Derivatives in Biological and Medicinal Chemistry |
(Eng)
|
|
Ratto A., Honek J.
|
| Volume 31, Nº 9 (2024) |
PAFAH1B3 Regulates Papillary Thyroid Carcinoma Cell Proliferation and Metastasis by Affecting the EMT |
(Eng)
|
|
Jiang W., Quan R., Bhandari A., Hirachan S., Chen C., Lv S., Zheng C.
|
| Volume 31, Nº 22 (2024) |
PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal |
(Eng)
|
|
Romo-Perez A., Domínguez-Gómez G., Chávez-Blanco A., González-Fierro A., Correa-Basurto J., Dueñas-González A.
|
| Volume 31, Nº 1 (2024) |
PBPK Modeling as an Alternative Method of Interspecies Extrapolation that Reduces the Use of Animals: A Systematic Review |
(Eng)
|
|
Lancheros Porras K., Alves I., Novoa D.
|
| Volume 31, Nº 11 (2024) |
Peptide Amphiphiles for Pharmaceutical Applications |
(Eng)
|
|
Fuertes-Llanos M., Gómara M., Haro I., Sánchez-López E.
|
| Volume 31, Nº 2 (2024) |
Peptide-based PROTACs: Current Challenges and Future Perspectives |
(Eng)
|
|
Wang H., Chen M., Zhang X., Xie S., Qin J., Li J.
|
| Volume 31, Nº 10 (2024) |
Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity |
(Eng)
|
|
Shayan S., Nasrollahi E., Bahramvand Y., Zarei M., Atarodi A., Farsi Y., Tavakolizadeh M., Shirvaliloo M., Abbasifard M., Jamialahmadi T., Banach M., Sahebkar A.
|
| Volume 31, Nº 22 (2024) |
Performance of Green Desymmetrization Methods toward Bioactive Cephalostatin Analogues |
(Eng)
|
|
Nawasreh M., Tahtamouni L.
|
| Volume 31, Nº 42 (2024) |
Perillyl Alcohol Promotes Relaxation in Human Umbilical Artery |
(Eng)
|
|
de Sena Bastos C., Pereira-de-Morais L., de Alencar Silva A., de Menezes Dantas D., Batista P., Gomes M., de Araújo Delmondes G., de Menezes I., da Silva R., Barbosa R.
|
| Volume 31, Nº 41 (2024) |
Periodontitis Continuum: Antecedents, Triggers, Mediators, and Treatment Strategies |
(Eng)
|
|
Gasmi Benahmed A., Tippairote T., Gasmi A., Noor S., Avdeev O., Shanaida Y., Mojgani N., Emadali A., Dadar M., Bjørklund G.
|
| Volume 31, Nº 8 (2024) |
Perspective and Prospects on Persistent Luminescent Nanoparticles for Biological Imaging and Tumor Therapy |
(Eng)
|
|
Sun M., Chen M., Wang J.
|
| Volume 31, Nº 3 (2024) |
Perspectives and Prospects on the Application of DNA Aptamer in SARS-CoV-2 |
(Eng)
|
|
Liu Y., Hu B., Li J., Pei X., Hu X.
|
| Volume 31, Nº 12 (2024) |
Perspectives on Iron Deficiency as a Cause of Human Disease in Global Public Health |
(Eng)
|
|
Bjørklund G., Semenova Y., Hangan T., Pen J., Aaseth J., Peana M.
|
| Volume 31, Nº 22 (2024) |
Pharmacokinetics of Anti-rheumatic Drugs Methotrexate and Tofacitinib with its Metabolite M9 in Rats by UPLC-MS/MS |
(Eng)
|
|
Gu E., Xue L., Zhou C., Xia Y., Dai G.
|
| Volume 31, Nº 5 (2024) |
Pharmacophore & QSAR Guided Design, Synthesis, Pharmacokinetics and In vitro Evaluation of Curcumin Analogs for Anticancer Activity |
(Eng)
|
|
Alam S., Verma S., Fatima K., Luqman S., Srivastava S., Khan F.
|
| Volume 31, Nº 3 (2024) |
Phosphate Prodrugs: An Approach to Improve the Bioavailability of Clinically Approved Drugs |
(Eng)
|
|
Tantra T., Singh Y., Patekar R., Kulkarni S., Kumar P., Thareja S.
|
| Volume 31, Nº 32 (2024) |
Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma |
(Eng)
|
|
Rayginia T., Keerthana C., Shifana S., Pellissery M., Abhishek A., Anto R.
|
| Volume 31, Nº 34 (2024) |
Phytochemicals as Substances that Affect Astrogliosis and their Implications for the Management of Neurodegenerative Diseases |
(Eng)
|
|
Forouzanfar F., Pourbagher-Shahri A., Vafaee F., Sathyapalan T., Sahebkar A.
|
| Volume 31, Nº 32 (2024) |
Phytochemicals as Therapeutic Agents against Cancer |
(Eng)
|
|
Bharti A.
|
| Volume 31, Nº 30 (2024) |
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults |
(Eng)
|
|
De S.
|
| Volume 31, Nº 39 (2024) |
PLGA Nanoparticles as New Drug Delivery Systems in Leishmaniasis Chemotherapy: A Review of Current Practices |
(Eng)
|
|
Valiallahi A., Vazifeh Z., Gatabi Z., Davoudi M., Gatabi I.
|
| Volume 31, Nº 37 (2024) |
Polyphenolic Nano-formulations: A New Avenue against Bacterial Infection |
(Eng)
|
|
Farhadi F., Eghbali S., Torabi Parizi S., Jamialahmadi T., Gumpricht E., Sahebkar A.
|
| Volume 31, Nº 42 (2024) |
Porphyrinuria in Autism Spectrum Disorder: A Review |
(Eng)
|
|
Bjørklund G., Semenova Y., El-Ansary A., Al-Ayadhi L.
|
| Volume 31, Nº 22 (2024) |
Potential Drugs in COVID-19 Management |
(Eng)
|
|
Gasmi A., Noor S., Menzel A., Khanyk N., Semenova Y., Lysiuk R., Beley N., Bolibrukh L., Gasmi Benahmed A., Storchylo O., Bjørklund G.
|
| Volume 31, Nº 19 (2024) |
Potential Role of Bone Metabolism Markers in Kidney Transplant Recipients |
(Eng)
|
|
Vigil F., Castro P., Hasparyk U., Bartolomei V., Silva A.
|
| Volume 31, Nº 21 (2024) |
Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2 |
(Eng)
|
|
Prabhakar P., Batiha G.
|
| Volume 31, Nº 26 (2024) |
Prediction Model for Therapeutic Responses in Ovarian Cancer Patients using Paclitaxel-resistant Immune-related lncRNAs |
(Eng)
|
|
Li X., Liu H., Wang F., Yuan J., Guan W., Xu G.
|
| Volume 31, Nº 31 (2024) |
Prediction of Human Microbe-Drug Association based on Layer Attention Graph Convolutional Network |
(Eng)
|
|
Qu J., Ni J., Ni T., Bian Z., Liang J.
|
| Volume 31, Nº 36 (2024) |
Predictive Analysis of Yi-Gai-San's Multifaceted Mechanisms for Tremor-dominant Parkinson's Disease via Network Pharmacology and Molecular Docking Validation |
(Eng)
|
|
Lin C., Wu L., Tsai F.
|
| Volume 31, Nº 1 (2024) |
Preface |
(Eng)
|
|
Atta-ur-Rahman .
|
| Volume 31, Nº 30 (2024) |
Probiotics for Inflammatory Bowel Disease; A Deep Dive into their Impact on Disease Course and Associated Health Risks |
(Eng)
|
|
Hassan W., Al-kaabi M., Akram N., Kassim M., Pantazi A.
|
| Volume 31, Nº 7 (2024) |
Prof. Dr. Ferid Murad (Nobel Laureate), a Great Friend of Bentham Science, Dies at the Age of 86 |
(Eng)
|
|
|
| Volume 31, Nº 42 (2024) |
Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer |
(Eng)
|
|
Tian Y., Xie Y., Yi G., Wu F., Dang X., Bai F., Wang J., Zhang D.
|
| Volume 31, Nº 29 (2024) |
Promises and Pitfalls of Calcineurin Inhibitors in COVID-19: A Systematic Review and Meta-analysis of Controlled Trials |
(Eng)
|
|
Heydari B., Sahebnasagh A., Omrani M., Azimi S., Dehghani M., Salehi-Abargouei A., Farman F., Saghafi F.
|
| Volume 31, Nº 25 (2024) |
Protective Effects of Curcumin and its Analogues via the Nrf2 Pathway in Metabolic Syndrome |
(Eng)
|
|
Rajabi S., Darroudi M., Naseri K., Farkhondeh T., Samarghandian S.
|
| Volume 31, Nº 24 (2024) |
Protective Roles and Therapeutic Effects of Gallic Acid in the Treatment of Cardiovascular Diseases: Current Trends and Future Directions |
(Eng)
|
|
Momeni Z., Danesh S., Ahmadpour M., Eshraghi R., Farkhondeh T., Pourhanifeh M., Samarghandian S.
|
| Volume 31, Nº 3 (2024) |
Protein Folding and Molecular Basis of Memory: Molecular Vibrations and Quantum Entanglement as Basis of Consciousness |
(Eng)
|
|
Atta-ur-Rahman .
|
| Volume 31, Nº 6 (2024) |
Purine Nucleosides and Analogues Bearing Chiral Substituents: Medicinal Chemistry and Therapeutic Perspective |
(Eng)
|
|
Drenichev M., Borokh V.
|
| Volume 31, Nº 8 (2024) |
Pyrazolo[4,3-H]quinazolines as Cyclin-dependent Kinase Inhibitors for Treating Cancer |
(Eng)
|
|
De S.
|
| Volume 31, Nº 36 (2024) |
Pyrrolo[2,3-D]Pyrimidines as EGFR and VEGFR Kinase Inhibitors: A Comprehensive SAR Review |
(Eng)
|
|
Metwally K., Abo-Dya N.
|
| Volume 31, Nº 40 (2024) |
Quantitative Structure-activity Relationship (QSAR) Modelling of Indomethacin Derivatives using Regression Analysis |
(Eng)
|
|
Shukla N., Sharma B.
|
| Volume 31, Nº 33 (2024) |
Radiotherapy-associated Sensorineural Hearing Loss in Pediatric Oncology Patients |
(Eng)
|
|
Aslam M., Ahmad H., Malik H., Uinarni H., Karim Y., Akhmedov Y., Abdelbasset W., Awadh S., Abid M., Mustafa Y., Farhood B., Sahebkar A.
|
| Volume 31, Nº 37 (2024) |
Recent Advancements in the Treatment of Alzheimers Disease: A Multitarget-directed Ligand Approach |
(Eng)
|
|
Kumar S., Mahajan A., Ambatwar R., Khatik G.
|
| Volume 31, Nº 4 (2024) |
Recent Advances and Techniques for Identifying Novel Antibacterial Targets |
(Eng)
|
|
Qiu J., Tang Z., He Y., Nazli A.
|
| Volume 31, Nº 26 (2024) |
Recent Advances in Protein Folding Pathway Prediction through Computational Methods |
(Eng)
|
|
Zhao K., Liang F., Xia Y., Hou M., Zhang G.
|
| Volume 31, Nº 18 (2024) |
Recent Advances in Research on Active Compounds Against Hepatic Fibrosis |
(Eng)
|
|
Liu C., Li S., Zhang C., Jin C.
|
| Volume 31, Nº 37 (2024) |
Recent Advances in the Synthesis and Analysis of Atorvastatin and its Intermediates |
(Eng)
|
|
Li S., Zhang W., Zhang W., Huang A., Zhu J., Wang Y., Zheng Y.
|
| Volume 31, Nº 20 (2024) |
Recent Advances on PKM2 Inhibitors and Activators in Cancer Applications |
(Eng)
|
|
Chen P., Lou L., Sharma B., Li M., Xie C., Yang F., Wu Y., Xiao Q., Gao L.
|
| Volume 31, Nº 17 (2024) |
Recent Advances on the Antimicrobial Activities of Schiff Bases and their Metal Complexes: An Updated Overview |
(Eng)
|
|
Jorge J., Del Pino Santos K., Timóteo F., Piva Vasconcelos R., Ignacio Ayala Cáceres O., Juliane Arantes Granja I., de Souza D., Allievi Frizon T., Di Vaccari Botteselle G., Luiz Braga A., Saba S., Rashid H., Rafique J.
|
| Volume 31, Nº 35 (2024) |
Recent Developments in Coumarin Derivatives as Neuroprotective Agents |
(Eng)
|
|
Mishra P., Kumar A., Kaur K., Jaitak V.
|
| Volume 31, Nº 10 (2024) |
Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human Coronavirus, and Enteroviruses |
(Eng)
|
|
De S.
|
| Volume 31, Nº 30 (2024) |
Recent Update on the Protective Potentials of Resveratrol against Cisplatin-induced Ototoxicity: A Systematic Review |
(Eng)
|
|
Alsaikhan F., Jasim S., Margiana R., Opulencia M., Yasin G., Hammid A., Nasretdinova M., Mahdi A., Farhood B., Abedi-Firouzjah R., Jamialahmadi T., Sahebkar A.
|
| Volume 31, Nº 25 (2024) |
Recent Updates on Interaction Studies and Drug Delivery of Antimalarials with Serum Albumin Proteins |
(Eng)
|
|
Azeem K., Irfan I., Rashid Q., Singh S., Patel R., Abid M.
|
| Volume 31, Nº 23 (2024) |
Recent Updates on Oncogenic Signaling of Aurora Kinases in Chemosensitive, Chemoresistant Cancers: Novel Medicinal Chemistry Approaches for Targeting Aurora Kinases |
(Eng)
|
|
Kumari P., Beeraka N., Tengli A., Bannimath G., Baath R., Patil M.
|
| Volume 31, Nº 34 (2024) |
Regulatory Non-coding RNAs Involved in Oxidative Stress and Neuroinflammation: An Intriguing Crosstalk in Parkinsons Disease |
(Eng)
|
|
Khish N., Ghiasizadeh P., Rasti A., Moghimi O., Zadeh A., Bahiraee A., Ebrahimi R.
|
| Volume 31, Nº 24 (2024) |
Research Progress in Estrogen-related Receptor Gamma (ERRγ) Agonists and Inverse Agonists |
(Eng)
|
|
Zheng Y., Du Y., Zhang H., Lv H., Yan Z., Dong N., Li Q., Wang T.
|
| 201 - 300 de 400 resultados |
<< < 1 2 3 4 > >> |
